Aelis Farma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 28

Employees

  • Stock Symbol
  • AELIS

Stock Symbol

  • Share Price
  • $1.30
  • (As of Friday Closing)

Aelis Farma General Information

Description

Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1 rue Lafaurie de Monbadon
  • 146, rue Léo Saignat
  • 33000 Bordeaux
  • France
+33 05
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PAR
Vertical(s)
Corporate Office
  • 1 rue Lafaurie de Monbadon
  • 146, rue Léo Saignat
  • 33000 Bordeaux
  • France
+33 05

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelis Farma Stock Performance

As of 20-Jun-2025, Aelis Farma’s stock price is $1.30. Its current market cap is $17.7M with 13.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.30 $1.30 $1.10 - $13.84 $17.7M 13.6M 30.4K -$0.60

Aelis Farma Financials Summary

As of 31-Dec-2024, Aelis Farma has a trailing 12-month revenue of $2.9M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 20,302 20,302 167,355 143,301
Revenue 2,898 2,898 9,797 4,005
EBITDA (7,766) (7,766) (5,409) (14,811)
Net Income (8,068) (8,068) (5,495) (15,022)
Total Assets 20,506 20,506 29,051 42,057
Total Debt 6,332 6,332 4,467 4,101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aelis Farma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aelis Farma‘s full profile, request access.

Request a free trial

Aelis Farma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Aelis Farma‘s full profile, request access.

Request a free trial

Aelis Farma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain d
Drug Discovery
Bordeaux, France
28 As of 2024

Plymouth, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aelis Farma Competitors (2)

One of Aelis Farma’s 2 competitors is Zynerba Pharmaceuticals, a Formerly VC-backed company based in Plymouth, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zynerba Pharmaceuticals Formerly VC-backed Plymouth, PA
Ambrx Formerly PE-Backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Aelis Farma Patents

Aelis Farma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3669876-A1 3béta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders Inactive 18-Dec-2018
EP-3897655-A1 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders Active 18-Dec-2018
JP-2022515373-A 3β- (benzyloxy) -17α-methyl-pregun-5-en-20-on for use in the treatment of cognitive impairment Active 18-Dec-2018
AU-2019409912-A1 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders Active 18-Dec-2018
AU-2019409912-A8 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders Active 18-Dec-2018 C07J7/009
To view Aelis Farma’s complete patent history, request access »

Aelis Farma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aelis Farma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aelis Farma‘s full profile, request access.

Request a free trial

Aelis Farma ESG

Risk Overview

Risk Rating

Updated December, 01, 2023

26.97 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,048

Rank

Percentile

Pharmaceuticals

Industry

of 914

Rank

Percentile

Biotechnology

Subindustry

of 404

Rank

Percentile

To view Aelis Farma’s complete esg history, request access »

Aelis Farma FAQs

  • When was Aelis Farma founded?

    Aelis Farma was founded in 2013.

  • Where is Aelis Farma headquartered?

    Aelis Farma is headquartered in Bordeaux, France.

  • What is the size of Aelis Farma?

    Aelis Farma has 28 total employees.

  • What industry is Aelis Farma in?

    Aelis Farma’s primary industry is Drug Discovery.

  • Is Aelis Farma a private or public company?

    Aelis Farma is a Public company.

  • What is Aelis Farma’s stock symbol?

    The ticker symbol for Aelis Farma is AELIS.

  • What is the current stock price of Aelis Farma?

    As of 20-Jun-2025 the stock price of Aelis Farma is $1.30.

  • What is the current market cap of Aelis Farma?

    The current market capitalization of Aelis Farma is $17.7M.

  • What is Aelis Farma’s current revenue?

    The trailing twelve month revenue for Aelis Farma is $2.9M.

  • Who are Aelis Farma’s competitors?

    Zynerba Pharmaceuticals and Ambrx are competitors of Aelis Farma.

  • What is Aelis Farma’s annual earnings per share (EPS)?

    Aelis Farma’s EPS for 12 months was -$0.60.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »